Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: The potential importance of bacterial translocation

International Journal of Cardiology

Volumn 72, Issue 1, 1999, Pages 3-10

  Brunkhorst, Frank M ^a   Clark, Andrew L ^b   Forycki, Zdziflaw F ^a   Anker, Stefan D ^c,d  

^a MARTIN LUTHER KRANKENHAUS   (Germany)

^b Castlehill Hospital   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Acute heart failure; Bacterial endotoxin; Cardiogenic shock; Cytokines; Procalcitonin

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; ENDOTOXIN; INTERLEUKIN 6; NEOPTERIN; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; BACTERIAL TRANSLOCATION; BLOOD LEVEL; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CONTROLLED STUDY; FEVER; HUMAN; HYPOTHESIS; IMMUNOSTIMULATION; INTENSIVE CARE UNIT; INTESTINE MUCOSA PERMEABILITY; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; SEPTIC SHOCK; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; BACTERIAL TRANSLOCATION; CALCITONIN; CYTOKINES; ENDOTOXINS; FEMALE; FEVER OF UNKNOWN ORIGIN; HUMANS; MALE; MIDDLE AGED; PROTEIN PRECURSORS; SHOCK, CARDIOGENIC; SHOCK, SEPTIC; SURVIVAL ANALYSIS;

EID: 0033573251     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(99)00118-7     Document Type: Article

References (38)

1. Anker S.D., Chua T.P., Ponikowski P., Harrington D., Swan J.W., Kox W.J., Poole-Wilson P.A., Coats A.J.S. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance in cardiac cachexia. Circulation. 96:1997;526-534.
2. Levine B., Kalman J., Mayer L., Fillit H., Packer M. Elevated circulating levels of tumour necrosis factor in severe chronic heart failure. New Engl J Med. 323:1990;236-241.
3. McMurray J., Abdullah I., Dargie H.J., Shapiro D. Increased concentrations of tumour necrosis factor in cachectic patients with severe chronic heart failure. Br Heart J. 66:1991;356-358.
4. Anker S.D., Egerer K.R., Volk H.-D., Kox W., Poole-Wilson P.A., Coats A.J.S. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol. 79:1997;1426-1430.
5. Niebauer J., Volk H.-D., Kemp M., Dominguez M., Schumann R.R., Rauchhaus M., Poole-Wilson P.A., Coats A.J.S., Anker S.D. Endotoxin and immune activation in chronic heart failure: A prospective cohort study. Lancet. 353:1999;1838-1842.
6. McLean G.W., Rabin D., Moore L., et al. Evaluation of provocative tests in suspected medullary thyroid carcinoma of the thyroid: Heterogeneity of calcitonin responses to calcium and pentagastrin. Metabolism. 33:1984;790-796.
7. Stepanas A.V., Samaan N.A., Hill C.S., et al. Medullary thyroid carcinoma. Cancer. 43:1978;825-837.
8. Milhaud G., Calmette C., Taboulet J.J., Julienne A., Moukhtar M. Hypersecretion of calcitonin in neoplastic conditions. Lancet. I:1974;462-463.
9. Becker K.L., Nash D.R., Silva O.L., et al. Increased serum and urinary calcitonin levels in patients with pulmonary disease. Chest. 79:1981;211-216.
10. Silva O., Becker K.L., Shaloub R.J., Snider R.H., Bivins L.E., Moore C.F. Calcitonin levels in chronic renal disease. Nephron. 19:1977;12-18.
11. Canale D.D., Donabedian R.K. Hypercalcitoninaemia in acute pancreatitis. J Clin Endocrinol Metab. 40:1975;738-740.
12. Heath H., Sizemore G.W., Larson J.M., Jerpback C.M. Immunochemical heterogeneity of calcitonin in tumor, tumor venous effluent and peripheral blood of patients with medullary thyroid carcinoma. J Lab Clin Med. 93:1979;390-394.
13. Deftos U., Ross B.A., Bronzert D., Pathermore J.G. Immunochemical heterogeneity of calcitonin in plasma. J Clin Endocrinol Metab. 40:1975;409-412.
14. Ghillani P., Motte P., Troalen F., et al. Identification and measurement of calcitonin precursors in serum of patients with malignant diseases. Cancer Res. 49:1989;6845-6851.
15. Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J., Bohoun C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 341:1993;515-518.
16. Brunkhorst F., Forycki Z.F., Beier W., Wagner J. Early identification of biliary pancreatitis with procalcitonin - A new inflammatory parameter. Gut. 37:(suppl 2):1995;A111.
17. Hatherill M., Jones G., Lim E., Tibby S.M., Murdoch I.A. Procalcitonin aids in the diagnosis of adrenocortical failure. Lancet. 350:1997;1749-1750.
18. Eberhard O.K., Langefeld I., Kuse E.R., Brunkhorst F.M., Kliem V., Schlitt H.J., Pichlmayr R., Koch K.M., Brunkhorst R. Procalcitonin in the early phase after renal transplantation - Will it add to diagnostic accuracy? Clin Transplant. 12:1998;206-211.
19. Dandona P., Nix D., Wilson M.F., Aljada A., Love J., Assicot M., Bohoun C. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 79:1994;1605-1608.
20. Brunkhorst F.M., Heinz U., Forycki Z.F. Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med. 24:1998;888-889.
21. Cohn A.E., Steele J.M. Unexplained fever in heart failure. J Clin Invest. 13:1934;853-868.
22. Yan S.F., Tritto I., Liao H., Huang J., Fuller G., Brett J., May L., Stern D. Induction of interleukin-6 (IL-6) by hypoxia in vascular cells. J Biol Chem. 270:1995;11463-11471.
23. Yamauchi-Takihara K., Ihara Y., Ogata A., Yoshizaki K., Azuma J., Kishimoto T. Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation. 91:1995;1520-1524.
24. Califf R.M., Bengtson J.R. Cardiogenic shock. N Engl J Med. 330:1994;1724-1730.
25. Bone R.C., Fisher C.J., Clemmer T.P., Slotman G.J., Metz C.A., Balk R.A. The Methylprednisolone Severe Sepsis Study Group. Sepsis syndrome: A valid clinical entity. Crit Care Med. 17:1989;389-393.
26. Deswal A., Bozkurt B., Seta Y., Parilti-Eiswirth S., Hayes F.A., Blosch C., Mann D.L. Safety and efficacy of a soluble tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation. 99:1999;3224-3226.
27. Mann D.L. Inflammatory mediators in heart failure: Homogeneity through heterogeneity. Lancet. 353:1999;1812-1813.
28. De Werra I., Jaccard C., Corradin S.B., Chioléro R., Yersin B., Gallati H., Assicot M., Bohuon C., Baumgartner J.-D., Glauser M.P., Heumann D. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med. 25:1997;607-613.
29. Vonhof S., Brost B., Stille-Siegener M., Grumbach I.M., Kreuzer H., Figulla H.R. Monocyte activation in congestive heart failure due to coronary artery disease and idiopathic dilated cardiomyopathy. Int J Cardiol. 63:1998;237-244.
30. Anker S.D., Clark A.L., Kemp M., Salsbury C., Teixeira M.M., Hellewell P.G., Coats A.J.S. Tumour necrosis factor and steroid metabolism in chronic heart failure: Possible relation to muscle wasting. J Am Coll Cardiol. 30:1997;997-1001.
31. Schumann R.R., Leong S.R., Flaggs G.W., Gray P.W., Wright S.D., Mathison J.C., Tobias P.S., Ulevitch R.J. Structure and function of lipopolysaccharide binding protein. Science. 249:1990;1429-1431.
32. Wagner D.R., McTiernan C., Sanders V.J., Feldman A.M. Adenosine inhibits lipopolysaccharide-induced secretion of tumor necrosis factor-alpha in the failing human heart. Circulation. 97:1998;521-524.
33. Anker S.D., Volterrani M., Egerer K.R., Felton C.V., Kox W.J., Poole-Wilson P.A., Coats A.J.S. Tumor necrosis factor-α as a predictor of peak leg blood flow in patients with chronic heart failure. Q J Med. 91:1998;199-203.
34. Hubacek J.A., Pit'ha J., Skodova Z., Stanek V., Poledne R. C (-260)→T polymorphism in the promotor of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation. 99:1999;3218-3220.
35. Rau B., Steinbach G., Gansauge F., Mayer J.M., Grunert A., Beger H.G. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut. 41:1997;832-840.
36. Torre-Amione G., Bozkurt B., Deswal A., Mann D.L. An overview of tumor necrosis factor alpha and the failing human heart. Curr Opin Cardiol. 14:1999;206-210.
37. Anker S.D., Ponikowski P.P., Clark A.L., Leyva F., Kemp M., Rauchhaus M., Hooper J., PooleWilson P.A., Coats A.J.S. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J. 20:1999;683-693.
38. Dibbs Z., Thornby J., White B.G., Mann D.L. Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: Implications for clinical trials. J Am Coll Cardiol. 33:1999;1935-1942.